Source:http://linkedlifedata.com/resource/pubmed/id/15878266
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-8-8
|
pubmed:abstractText |
[(3)H]luteolin covalently labels two forms (11kDa and 35kDa proteins) of type II binding sites in rat uterine nuclear extracts [K. Shoulars, T. Brown, M. Alejandro, J. Crowley, B. Markaverich, Identification of rat uterine nuclear type II [(3)H]estradiol binding sites as histone H4, Biochem. Biophys. Res. Commun. 296 (2002) 1083-1090]. The 11kDa protein was identified as histone H4. Levels of the 35kDa protein were insufficient for sequencing; however, this protein was recognized by anti-histone H4 antibodies. Histones H3 and H4 exist as dimers in vivo (mw>>35kDa) and we suspected the 35kDa [(3)H]luteolin-labeled protein in uterine nuclear extracts might be a complex of histones H3 and H4. This manuscript describes methods for the purification of commercially available calf thymus core histones that retain [(3)H]luteolin binding activity and are of sufficient purity for recombination studies. Mixing experiments with pure H3 and H4 from calf thymus demonstrate that a 35kDa H3-H4 dimer capable of binding [(3)H]luteolin is generated and this protein appears equivalent to the 35kDa [(3)H]luteolin binding protein in rat uterine nuclear extracts. If this is the case, type II site ligands including MeHPLA, luteolin, and other bioflavonoids and phytoestrogens may control histone-dependent gene transcription and cellular proliferation via binding to and modulating core histone/nucleosome function.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA 35480,
http://linkedlifedata.com/resource/pubmed/grant/CA 98007,
http://linkedlifedata.com/resource/pubmed/grant/ES 009964,
http://linkedlifedata.com/resource/pubmed/grant/P30 DK 56341,
http://linkedlifedata.com/resource/pubmed/grant/P41 RR 00954,
http://linkedlifedata.com/resource/pubmed/grant/P60 DK 20579
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0960-0760
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-30
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15878266-Animals,
pubmed-meshheading:15878266-Binding Sites,
pubmed-meshheading:15878266-Breast Neoplasms,
pubmed-meshheading:15878266-Cell Line, Tumor,
pubmed-meshheading:15878266-Cell Nucleus,
pubmed-meshheading:15878266-Chromatography, High Pressure Liquid,
pubmed-meshheading:15878266-Estradiol,
pubmed-meshheading:15878266-Female,
pubmed-meshheading:15878266-Histones,
pubmed-meshheading:15878266-Humans,
pubmed-meshheading:15878266-Protein Isoforms,
pubmed-meshheading:15878266-Rats,
pubmed-meshheading:15878266-Rats, Sprague-Dawley,
pubmed-meshheading:15878266-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:15878266-Uterus
|
pubmed:year |
2005
|
pubmed:articleTitle |
Nuclear type II [3H]estradiol binding sites: a histone H3-H4 complex.
|
pubmed:affiliation |
Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|